The efficacy of sequential therapy with docetaxel and cabazitaxel for castration-resistant prostate cancer: A retrospective multi-institutional study in Japan.
Terada N, Sawada A, Kawanishi H, Fujimoto T, Magaribuchi T, Chihara I, Hashimoto K, Sakurai T, Shimizu Y, Uegaki M, Nakashima M, Narita S, Kubota M, Yamada Y, Tohi Y, Okabe K, Yatsuda J, Kamoto T.
Terada N, et al. Among authors: kamoto t.
Int J Urol. 2023 Feb;30(2):227-234. doi: 10.1111/iju.15097. Epub 2022 Nov 14.
Int J Urol. 2023.
PMID: 36375045